Almac Announces Expansion to its Commercial Facility With the Addition of Increased Storage Capacity for Biologic Products

CRAIGAVON, Northern Ireland, March 25, 2011 - In response to increased client demand for cold and dedicated
frozen storage capacity for biopharmaceuticals, Almac's Pharma Services
business unit has expanded its commercial facilities to include an additional
6124 sq ft of cold and frozen storage.

This is a joint investment with a commercial client, for which
Almac provides central EU importation, warehousing and distribution services.
This includes dedicated -70degreesC, -20degreesC and 2-8degreesC storage for
drug antibody, drug linker, bulk drug substance, placebo and filled vials,
coupled to before and after distribution to various global processing
facilities.

In preparation for the successful commercialisation of the
drug product, 20 additional dedicated freezer units have been added to the
existing 10, for the storage of the monoclonal antibody and bulk drug
substance products.

Strengthening Almac's EU product launch services, the
expansion has also resulted in increased floor space facilitating shipping
system configuration for bulk drug product and for direct to pharmacy supply
of niche orphan drug products.

David Downey, Vice President, Commercial Operations comments
"It is a pleasure to be able to expand our scope of services through this
shared investment. Our ability to ensure all necessary preparations are made
for this important commercial launch, positions Almac well within this
growing biopharmaceutical sector".

About Almac

The Almac Group offers a broad range of services from R&D,
biomarker discovery and development, API manufacture, pharmaceutical
development, clinical trial supply and IXRS technology (IVRS/IWRS), to
commercial-scale manufacture and packaging. Almac provides services to more
than 600 companies, including all the world leaders in the pharmaceutical and
biotech sectors.

The company employs almost 3,000 individuals and is
headquartered in Craigavon, Northern Ireland. US operations are based in
Pennsylvania, North Carolina and California. Staff have now transferred to
Almac's new $120m North American Headquarters which is now fully operational.

For more information about the Almac Group, please visit
www.almacgroup.com or e-mail info@almacgroup.com

    For Further information contact:

    Almac
    Tania Davis
    T: +44(0)28-3836-363
    E: Tania.davis@almacgroup.com

For Further information contact: Almac, Tania Davis, T: +44(0)28-3836-363, E: Tania.davis at almacgroup.com